Related references
Note: Only part of the references are listed.PET Tumor Metabolism in Locally Advanced Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy: Value of Static versus Kinetic Measures of Fluorodeoxyglucose Uptake
Lisa K. Dunnwald et al.
CLINICAL CANCER RESEARCH (2011)
Staging of Breast Cancer with Ultrasound
Wei Tse Yang
SEMINARS IN ULTRASOUND CT AND MRI (2011)
Feasibility of FDG PET/CT to monitor the response of axillary lymph node metastases to neoadjuvant chemotherapy in breast cancer patients
Marieke E. Straver et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2010)
Value of PET-FDG in primary breast cancer based on histopathological and immunohistochemical prognostic factors
Pierre Heudel et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2010)
18F-FDG PET of Locally Invasive Breast Cancer and Association of Estrogen Receptor Status with Standardized Uptake Value: Microarray and Immunohistochemical Analysis
Joseph R. Osborne et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
18F-FDG PET/CT for early prediction of response to neoadjuvant chemotherapy in breast cancer
Joan Duch et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2009)
Imaging bone metastases in breast cancer: techniques and recommendations for diagnosis
Colleen M. Costelloe et al.
LANCET ONCOLOGY (2009)
Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters
Sandip Basu et al.
CANCER (2008)
Clinicopathological and prognostic relevance of uptake level using F-18-fluorodeoxyglucose positron emission tomography/computed tomography fusion imaging (F-18-FDG PET/CT) in primary breast cancer
Shigeto Ueda et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2008)
Is there a role for positron emission tomography in breast cancer staging?
Nicole C. Hodgson et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
[18F]FDG-PET predicts complete pathological response of breast cancer to neoadjuvant chemotherapy
Alina Berriolo-Riedinger et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2007)
American society of clinical oncology 2007 update of recommendations for the use of tumor markers in breast cancer
Lyndsay Harris et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
[Anonymous]
JOURNAL OF ONCOLOGY PRACTICE (2007)
The effects of estrogen, progesterone, and C-erbB-2 receptor states on 18F-FDG uptake of primary breast cancer lesions
Ayse Mavi et al.
JOURNAL OF NUCLEAR MEDICINE (2007)
FDG uptake in breast cancer:: correlation with biological and clinical prognostic parameters
A Buck et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2002)
Biologic correlates of 18fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography
R Bos et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Axillary lymph node staging in breast cancer by 2-fluoro-2-deoxy-D-glucose-positron emission tomography: Clinical evaluation and alternative management
M Greco et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)